Grant: Operating Grant
McGill University
$296,235.00
Targeting the editosome in Trypanosoma brucei - from function to drug discovery
FY 2011-12
Summary
RNA editing, catalyzed by a multi-protein complex, is an essential process for viability of parasitic pathogens and hence a drug target. These parasitic pathogens are responsible for serious human diseases of African sleeping sickness, Chagas disease, and leishmaniasis. With a mortality rate of 50,000 individuals per year, leishmaniasis is the second most important parasitic infection after malaria, followed by African sleeping sickness with 48,000 deaths per year. Chagas disease also causes 15,000 deaths annually. Transmissions of trypanosomatids are of growing concern as a result of transfusion and organ donation in the industrialized countries such as Canada and US. Canadians, new immigrants to Canada, and soldiers returning from Afghanistan, are also at risk. There are no vaccines for these pathogens, the drugs are toxic with limited effectiveness, and drug resistance is emerging. This project is focused on characterization of essential proteins involved in RNA editing. We will characterize these proteins in detail and identify specific inhibitors against these proteins. The inhibitors will be used to interfere with their functions to determine their exact role in RNA editing. They can also be exploited to develop the means to prevent disease caused by these pathogens.
Department
Program
Operating Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
239708
Name
Salavati Reza
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Targeting the editosome in Trypanosoma brucei - from function to drug discovery
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$296,235
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Biochemistry; Chemical Screen; Drug Target Characterization; Enzyme Kinetics; Rna Processing
Abstract
RNA editing, catalyzed by a multi-protein complex, is an essential process for viability of parasitic pathogens and hence a drug target. These parasitic pathogens are responsible for serious human diseases of African sleeping sickness, Chagas disease, and leishmaniasis. With a mortality rate of 50,000 individuals per year, leishmaniasis is the second most important parasitic infection after malaria, followed by African sleeping sickness with 48,000 deaths per year. Chagas disease also causes 15,000 deaths annually. Transmissions of trypanosomatids are of growing concern as a result of transfusion and organ donation in the industrialized countries such as Canada and US. Canadians, new immigrants to Canada, and soldiers returning from Afghanistan, are also at risk. There are no vaccines for these pathogens, the drugs are toxic with limited effectiveness, and drug resistance is emerging. This project is focused on characterization of essential proteins involved in RNA editing. We will characterize these proteins in detail and identify specific inhibitors against these proteins. The inhibitors will be used to interfere with their functions to determine their exact role in RNA editing. They can also be exploited to develop the means to prevent disease caused by these pathogens.
Competitiondate
201109
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Salavati, Reza
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $296,235~ $0~